Cognitive Risk Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A Mendelian randomization study appears to exonerate very low LDL-C but not therapies from altering cognition.

Falkw lohoffNational institute of alcohol abuseUniversity of cambridge englandUniversity of oxford englandUs national institutes of healthNational instituteAlcohol abuseCognitive risk factorIpid managementRoprotein convertase subtilisin kexin type 9Genomic medicineEdicine genomicLipid lowering drugsRug lipid loweringClinical researchClinical trials